Oyekoya T. Ayonrinde

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

Gender-Specific Differences in Adipose Distribution and Adipocytokines Influence Adolescent Nonalcoholic Fatty Liver Disease Δ

Oyekoya T. Ayonrinde, John K. Olynyk, Lawrence J. Beilin et al. · Hepatology · 2010 · 238 citations · Full text

Childhood adiposity trajectories and risk of nonalcoholic fatty liver disease in adolescents

Oyekoya T. Ayonrinde, John K. Olynyk, Julie Marsh et al. · Journal of Gastroenterology and Hepatology · 2014 · 125 citations

Infant nutrition and maternal obesity influence the risk of non-alcoholic fatty liver disease in adolescents

Oyekoya T. Ayonrinde, Wendy H. Oddy, Leon A. Adams et al. · Journal of Hepatology · 2017 · 125 citations · Full text

Obesity, Metabolic Syndrome, Nutrition +13

The impact of phlebotomy in nonalcoholic fatty liver disease: A prospective, randomized, controlled trial

Leon A. Adams, Dorothy H. Crawford, Katherine Stuart et al. · Hepatology · 2014 · 111 citations